By South Asia Monitor/JEN | @justearthnews | 16 Jun 2021, 08:29 am Print
Johnson and Johnson Image: Wikimedia Commons
Bangladesh has approved Johnson and Johnson’s single-dose Covid-19 for emergency use in the country, making it the sixth vaccine to get approval. The country is all set to resume its national vaccination campaign on Saturday.
On Tuesday, the country’s Directorate-General of Drug Administration (DGDA) has granted emergency use approval to the vaccine after scrutinized all document and clinal trial data submitted by the manufacturer, reported Dhaka Tribune.
So far, it has approved six vaccines for usage in the country: AstraZeneca-Oxford vaccine, Sputnik-V, Pfizer, Sinopharm, and Sinovac. However, Astra-Zeneca and Sinopharm are the two main vaccines used for the national vaccination drive.
The supply of the Astra-Zeneca/Covishield vaccine was disrupted in April this year following the disastrous Covid-19 surge in India, prompting the Indian government to halt the export.
- New study shows chronic disease deaths are declining globally but progress is slowing
- WHO says cholera kills more people for second consecutive year
- Experts feel that overweight and obesity are rising across all ages in India
- WHO says more than 720,000 people commit suicide every year
- UNICEF report shows obesity has surpassed underweight
